Started reconstituted tirz March 2024 after several months on compounding pharmacy. Vial longevity is something I think about differently bc of sleeve (2017). My bariatric surgeon had me hold 2.5mg for 8 weeks before moving up, not the standard 4-week ramp. The sleeve handles restriction, the GLP-1 handles hunger signaling, so there’s less urgency to push dose quickly. That slower pace changes the math. At 2.5mg/week a 10mg vial is 4 weeks of doses. I was on my third vial before I even hit 5mg. My personal limit: 8 weeks on a properly stored reconstituted vial (bac water, 4C, away from light). Done it twice now. Potency felt consistent, side effect profile didn’t shift in a way that suggested degradation. I wouldn’t push to 12. The downside of a degraded vial isn’t just wasted money, it’s potentially weeks of underdosing without realizing it, and that’s a hard pattern to catch.
the underdosing detection point is the one that doesn’t get enough airtime. if potency drops gradually, there’s no moment where you notice. you just slowly stop responding as well and most people attribute it to tolerance or plateau rather than a degraded vial. that’s a genuinely hard pattern to catch, agreed. your bariatric context is useful framing here. the sleeve-plus-GLP-1 stack really does change the dosing urgency calculus. you’re not chasing hunger suppression the same way someone without restriction is, so the slower ramp actually makes sense physiologically, not just as caution. and slower ramp means more vial exposure time per mg tier. my situation is T2D no surgery, so my titration math looks different, but the storage discipline is the same: bac water, 4C, dark, and I track reconstitution date explicitly bc I’ve found I stop thinking abt it otherwise. 8 weeks is where I’d draw the line too, n=1. 12 feels like wishful thinking, especially when the consequence is invisible.
the invisible consequence point is exactly right, and it’s the part that makes potency drift genuinely different from other vial problems. a vial with particulate or discoloration you catch. gradual degradation you attribute to everything else first: sleep, stress, dietary slip, where you’re at in your cycle. i did 6 weeks on a vial last fall and spent two weeks second-guessing whether i was hitting a plateau before i even thought to check reconstitution date. tracked it down in my notes and that became my reason to start logging it more carefully. the explicit date tracking habit is underrated.
The point you’re making about underdosing being the real cost is the one I wish more people internalized. A degraded vial doesn’t announce itself. You don’t get a clean signal like “this is 60% potent now,” you get a slow drift in appetite suppression that’s easy to attribute to tolerance, stress, the season, whatever else is going on in your week. By the time you’d notice, you’re three or four doses deep into the slide and your reference point for “normal” has already moved. The bariatric framing is interesting and I don’t think I’ve seen it laid out this cleanly before. The standard titration schedule is built around people whose hunger signaling is the primary lever, so faster ramps make sense if the goal is getting to a therapeutic window before the patient gives up on side effects. If restriction is already doing structural work, the urgency calculus really does change, and stretching 2.5 across more weeks isn’t undertreatment, it’s just matching the dose to what the body actually needs. Whether 8 weeks at 2.5 is the right hold for any given person is a clinician call obviously, but the logic holds. On the 8 week vial limit: that lines up with where I land too, and for similar reasons. The stability data we have past 4 weeks gets thin fast, and the manufacturer’s 28 day number is conservative for liability reasons, not because something dramatic happens at day 29. Going to 12 weeks isn’t crazy on its face but you’re extrapolating well past the curve, and the asymmetry of the bet is bad. Saving a vial vs missing weeks of effective dosing is not a trade I’d make either. One thing worth tracking if you haven’t already: appetite return timing within the dosing week, not just average hunger. If a vial is degrading, the tail end of the week tends to feel different before the peak does. It’s a softer signal than weight or side effects but it usually shows up first.
the attribution spiral is real. sleep, stress, dietary slip, cycle - those are all plausible explanations and they’re all things you can’t rule out quickly. the vial date is the one variable that’s actually fixed and checkable, which is why it should come first in the troubleshoot order, not last. for me, the CGM catches it before I’d catch it otherwise. if my 14-day average starts drifting up without a clear lifestyle reason, that’s a signal worth investigating. n=1, and I don’t know if it’s sensitive enough to detect early drift, but having objective glucose data takes some of the “is this a plateau or is it me” guesswork out. do you log reconstitution date separately or just in general notes?